Nuvaring and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Nuvaring (ethinyl estradiol; etonogestrel), especially for people who are female, 20-29 old, have been taking the drug for 2 - 5 years also take Prozac, and have Rhinitis.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Nuvaring. It is created by eHealthMe based on reports of 27,664 people who have side effects when taking Nuvaring from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,073 drugs and 427 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

27,664 people reported to have side effects when taking Nuvaring.
Among them, 52 people (0.19%) have Conjunctivitis exacerbated.

Could Nuvaring cause Conjunctivitis exacerbated?

Among these 52 people:

How long have people been on Nuvaring when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Nuvaring? *

female: 100 %
male: 0.0 %

What is the age of people who have Conjunctivitis exacerbated when taking Nuvaring? *

What are other drugs people take besides Nuvaring? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 23 people, 44.23%
Pulmonary Embolism (blockage of the main artery of the lung): 20 people, 38.46%
Headache (pain in head): 19 people, 36.54%
Sinusitis (inflammation of sinus): 17 people, 32.69%
Urinary Tract Infection: 17 people, 32.69%
Depression: 16 people, 30.77%
Upper Respiratory Tract Infection: 14 people, 26.92%
Migraine (headache): 14 people, 26.92%
Abdominal Pain: 12 people, 23.08%
Muscle Spasms (muscle contraction): 12 people, 23.08%

What are the existing conditions these people have? *

Menstruation Irregular: 6 people, 11.54%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 6 people, 11.54%
Heavy Or Prolong Menstrual Bleeding: 4 people, 7.69%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 5.77%
Dysmenorrhea (painful menstruation): 3 people, 5.77%
Stress And Anxiety: 1 person, 1.92%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 1.92%
Gastrointestinal Hypomotility (less activity of the intestinal tract): 1 person, 1.92%
Headache (pain in head): 1 person, 1.92%
Itching: 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuvaring:

Nuvaring (28,730 reports)

Conjunctivitis exacerbated treatments and more:

Conjunctivitis exacerbated (5 reports)

How severe was Conjunctivitis exacerbated and when was it recovered:

Conjunctivitis exacerbated in Nuvaring

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Conjunctivitis exacerbated and drugs with ingredients of ethinyl estradiol; etonogestrel

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,073 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (427 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Nuvaring) and Nuvaring (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.